title: Efficacy of hydroxyethyl starch and haemaccel for the treatment of severe ovarian hyperstimulation syndrome.
authors.forename: Ronni
authors.initials: R
authors.lastname: Gamzu
authors.forename: Benny
authors.initials: B
authors.lastname: Almog
authors.forename: Yishai
authors.initials: Y
authors.lastname: Levin
authors.forename: Amiram
authors.initials: A
authors.lastname: Avni
authors.forename: Joseph B
authors.initials: JB
authors.lastname: Lessing
authors.forename: Amiram
authors.initials: A
authors.lastname: Baram
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011097:Polygeline / Q000627:therapeutic use*; D012720:Severity of Illness Index
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D011097:Polygeline